Peer-Reviewed Studies Flawed

[Monica]

Scientific peer reviews are a 'sacred cow' ready to be slaughtered, says former editor of BMJ

The peer review process – long considered the gold standard of quality scientific research – is a “sacred cow” that should be slaughtered, the former editor of one of the country’s leading medical journals has said.

Richard Smith, who edited the British Medical Journal for more than a decade, said there was no evidence that peer review was a good method of detecting errors and claimed that “most of what is published in journals is just plain wrong or nonsense”.

...

Speaking at a Royal Society event earlier this week, he said an experiment conducted during his time at the BMJ, in which eight deliberate errors were included in a short paper sent to 300 reviewers, had exposed how easily the peer review process could fail.

“No-one found more than five, the median was two, and 20 per cent didn’t spot any,” he was quoted as saying by Times Higher Education. “If peer review was a drug it would never get on the market because we have lots of evidence of its adverse effects and don’t have evidence of its benefit.”

He said the process of peer review before publication could also work against innovative papers, was open to abuse, and should be done away with in favour of “the real peer review” of the wider scientific community post-publication.

“It’s time to slaughter the sacred cow,” he said...

...

His comments come at a time of serious soul-searching within the scientific community, over the quality of much published research.

The editor of the second of the country’s two leading medical journals, Dr Richard Horton of The Lancet, wrote in an editorial earlier this month that “much of the scientific literature, perhaps half, may simply be untrue”, blaming, among other things, studies with small sample sizes, researchers’ conflicts of interest and “an obsession” among scientists for pursuing fashionable trends of dubious importance”.

“The apparent endemicity of bad research behaviour is alarming,” he wrote. “In their quest for telling a compelling story, scientists too often sculpt their data to fit their preferred theory of the world.”

[Indigo Light]

Yea this fits in great, for what the elite want. A scientific body just spouting out distortions.

[Monica]

Harvard Medical School in Ethics Quandary

The students argue, for example, that Harvard should be embarrassed by the F grade it recently received from the American Medical Student Association, a national group that rates how well medical schools monitor and control drug industry money...

...no one disputes that many individual Harvard Medical faculty members receive tens or even hundreds of thousands of dollars a year through industry consulting and speaking fees. Under the school’s disclosure rules, about 1,600 of 8,900 professors and lecturers have reported to the dean that they or a family member had a financial interest in a business related to their teaching, research or clinical care. The reports show 149 with financial ties to Pfizer and 130 with Merck.

The rules, though, do not require them to report specific amounts received for speaking or consulting, other than broad indications like “more than $30,000.” Some faculty who conduct research have limits of $30,000 in stock and $20,000 a year in fees. But there are no limits on companies’ making outright gifts to faculty — free meals, tickets, trips or the like.

Other blandishments include industry-endowed chairs like the three Harvard created with $8 million from sleep research companies; faculty prizes like the $50,000 award named after Bristol-Myers Squibb, and sponsorships like Pfizer’s $1 million annual subsidy for 20 new M.D.’s in a two-year program to learn clinical investigation and pursue Harvard Master of Medical Science degrees, including classes taught by Pfizer scientists.

Dr. Flier, who became dean 17 months ago, previously received a $500,000 research grant from Bristol-Myers Squibb. He also consulted for three Cambridge biotechnology companies, but says that those relationships have ended and that he has accepted no new industry affiliations.

That is in contrast to his predecessor as dean, Dr. Joseph B. Martin. Harvard’s rules allowed Dr. Martin to sit on the board of the medical products company Baxter International for 5 of the 10 years he led the medical school, supplementing his university salary with up to $197,000 a year from Baxter, according to company filings.

[VanAlioSaldo]

Factor in Corporate agendas alone and we'd all understand why the current science model is broken. Need this study done specifically? Here's 100k, legally.

Disinformation and Misinformation.

Be wary All. Follow the money.

[Monica]

Oopsie

http://www.huffingtonpost.ca/lawrence-so...81914.html

...